NCT02226367View on ClinicalTrials.gov

Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD

NACompletedINTERVENTIONAL

Enrollment

158

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

September 20, 2018

Study Completion Date

October 20, 2018

Conditions

Alcohol Use DisordersStress Disorders, PosttraumaticCombat Disorders

Interventions

DRUG

prazosin hydrochloride

study drug arm prazosin

DRUG

placebo

study drug arm placebo

Trial Locations (1)

98431

Madigan Army Medical Center, Tacoma

All Listed Sponsors

collaborator

United States Department of Defense

FED

collaborator

VA Puget Sound Health Care System

FED

lead

Seattle Institute for Biomedical and Clinical Research

OTHER

NCT02226367 - Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD | Biotech Hunter | Biotech Hunter